159 related articles for article (PubMed ID: 38040985)
1. Pharmacokinetic Parameters of Recombinant Human Cyclophilin A in Mice.
Kalinina A; Grigorieva E; Smirnova A; Kazansky D; Khromykh L
Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):57-69. PubMed ID: 38040985
[TBL] [Abstract][Full Text] [Related]
2. Cyclophilin A is a factor of antitumor defense in the early stages of tumor development.
Kalinina A; Golubeva I; Kudryavtsev I; Khromova N; Antoshina E; Trukhanova L; Gorkova T; Kazansky D; Khromykh L
Int Immunopharmacol; 2021 May; 94():107470. PubMed ID: 33640856
[TBL] [Abstract][Full Text] [Related]
3. Preparative Production and Purification of Recombinant Human Cyclophilin A.
Kalinina AA; Kolesnikov AV; Kozyr AV; Kulikova NL; Zamkova MA; Kazansky DB; Khromykh LM
Biochemistry (Mosc); 2022 Mar; 87(3):259-268. PubMed ID: 35526853
[TBL] [Abstract][Full Text] [Related]
4. Analyses of the toxic properties of recombinant human Cyclophilin A in mice.
Kalinina A; Zamkova M; Antoshina E; Trukhanova L; Gorkova T; Kazansky D; Khromykh L
J Immunotoxicol; 2019 Dec; 16(1):182-190. PubMed ID: 31646917
[TBL] [Abstract][Full Text] [Related]
5. Evidences of monomer, dimer and trimer of recombinant human cyclophilin A.
Zhang XC; Wang WD; Wang JS; Pan JC; Zou GL
Protein Pept Lett; 2011 Dec; 18(12):1188-93. PubMed ID: 21728990
[TBL] [Abstract][Full Text] [Related]
6. Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway.
Obchoei S; Sawanyawisuth K; Wongkham C; Kasinrerk W; Yao Q; Chen C; Wongkham S
Tumour Biol; 2015 Feb; 36(2):849-59. PubMed ID: 25296734
[TBL] [Abstract][Full Text] [Related]
7. PPIase independent chaperone-like function of recombinant human Cyclophilin A during arginine kinase refolding.
Zhang XC; Wang WD; Wang JS; Pan JC
FEBS Lett; 2013 Mar; 587(6):666-72. PubMed ID: 23376614
[TBL] [Abstract][Full Text] [Related]
8. The Role of Recombinant Human Cyclophilin A in the Antitumor Immune Response.
Kalinina AA; Silaeva YY; Kazansky DB; Khromykh LM
Acta Naturae; 2019; 11(2):63-67. PubMed ID: 31413881
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity.
Hong F; Lee J; Piao YJ; Jae YK; Kim YJ; Oh C; Seo JS; Yun YS; Yang CW; Ha J; Kim SS
Biochem Biophys Res Commun; 2004 Apr; 316(4):1073-80. PubMed ID: 15044094
[TBL] [Abstract][Full Text] [Related]
10. Secreted cyclophilin A is non-genotoxic but acts as a tumor promoter.
Kalinina A; Tilova L; Kirsanov K; Lesovaya E; Zhidkova E; Fetisov T; Ilyinskaya G; Yakubovskaya M; Kazansky D; Khromykh L
Toxicology; 2023 Dec; 500():153675. PubMed ID: 37993081
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Human Cyclophilin A in Combination with Adoptive T-cell Therapy Improves the Efficacy of Cancer Immunotherapy in Experimental Models in vivo.
Kalinina AA; Kazansky DB; Khromykh LM
Biochemistry (Mosc); 2023 May; 88(5):590-599. PubMed ID: 37331705
[TBL] [Abstract][Full Text] [Related]
12. The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A.
Waller H; Chatterji U; Gallay P; Parkinson T; Targett-Adams P
J Virol Methods; 2010 May; 165(2):202-10. PubMed ID: 20132841
[TBL] [Abstract][Full Text] [Related]
13. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
Chatterji U; Lim P; Bobardt MD; Wieland S; Cordek DG; Vuagniaux G; Chisari F; Cameron CE; Targett-Adams P; Parkinson T; Gallay PA
J Hepatol; 2010 Jul; 53(1):50-6. PubMed ID: 20451281
[TBL] [Abstract][Full Text] [Related]
14. Association of cyclophilin A with renal brush border membranes: redistribution by cyclosporine A.
Demeule M; Laplante A; Sepehr-Araé A; Murphy GM; Wenger RM; Béliveau R
Kidney Int; 2000 Apr; 57(4):1590-8. PubMed ID: 10760094
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of cyclophilin A against Alzheimer's amyloid beta-peptide (25-35)-induced oxidative stress in PC12 cells.
Ge YS; Teng WY; Zhang CD
Chin Med J (Engl); 2009 Mar; 122(6):716-24. PubMed ID: 19323941
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Cyclophilin A to determination of simian immunodeficiency virus tropism: a progress update.
Takeuchi H
Vaccine; 2010 May; 28 Suppl 2():B51-4. PubMed ID: 20510744
[TBL] [Abstract][Full Text] [Related]
17. Host cell species-specific effect of cyclosporine A on simian immunodeficiency virus replication.
Takeuchi H; Ishii H; Kuwano T; Inagaki N; Akari H; Matano T
Retrovirology; 2012 Jan; 9():3. PubMed ID: 22225545
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A Regulates Influenza A Virus-induced Macrophages Polarization and Inflammatory Responses by Targeting Cyclophilin A.
Bai X; Yang W; Li H; Zhao Y; Fan W; Zhang H; Liu W; Sun L
Front Immunol; 2022; 13():861292. PubMed ID: 35693825
[TBL] [Abstract][Full Text] [Related]
19. Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.
Yang F; Robotham JM; Nelson HB; Irsigler A; Kenworthy R; Tang H
J Virol; 2008 Jun; 82(11):5269-78. PubMed ID: 18385230
[TBL] [Abstract][Full Text] [Related]
20. A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach.
Yang F; Robotham JM; Grise H; Frausto S; Madan V; Zayas M; Bartenschlager R; Robinson M; Greenstein AE; Nag A; Logan TM; Bienkiewicz E; Tang H
PLoS Pathog; 2010 Sep; 6(9):e1001118. PubMed ID: 20886100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
